Total submissions: 16
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000039805 | SCV000063494 | likely benign | not specified | 2012-06-14 | criteria provided, single submitter | clinical testing | Ile112Ile in exon 2 of CAV3: This variant is not expected to have clinical signi ficance because it does not alter an amino acid residue and is not located withi n the splice consensus sequence. It has been identified in 0.2% (15/7020) of Eur opean American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS; dbSNP rs139985460). Ile112Ile in ex on 2 of CAV3 (rs139985460; allele frequency = 0.2%, 15/7020) ** |
Gene |
RCV000039805 | SCV000167540 | benign | not specified | 2012-04-03 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV001084064 | SCV000291182 | benign | Long QT syndrome | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000039805 | SCV000315209 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV000245826 | SCV000318861 | likely benign | Cardiovascular phenotype | 2015-06-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Eurofins Ntd Llc |
RCV000039805 | SCV000332623 | likely benign | not specified | 2015-07-08 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000769176 | SCV000900551 | benign | Cardiomyopathy | 2016-12-12 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000232287 | SCV001153762 | likely benign | not provided | 2023-05-01 | criteria provided, single submitter | clinical testing | CAV3: BP4, BP7 |
ARUP Laboratories, |
RCV000232287 | SCV001159719 | benign | not provided | 2019-10-31 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001144021 | SCV001304595 | benign | Caveolinopathy | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Fulgent Genetics, |
RCV002490551 | SCV002798910 | likely benign | Elevated circulating creatine kinase concentration; Hypertrophic cardiomyopathy 1; Long QT syndrome 9; Rippling muscle disease 2; Distal myopathy, Tateyama type | 2021-08-12 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000232287 | SCV001741710 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000039805 | SCV001797763 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000039805 | SCV001919617 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000039805 | SCV001927411 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000039805 | SCV001953841 | benign | not specified | no assertion criteria provided | clinical testing |